Nephros vs Jin Medical International
Nephros and Jin Medical International are similar in size: $18.8m and $20.7m of revenue in their latest fiscal years. Nephros grew faster (32.7% against -12.0%). Nephros kept more of each dollar of sales as profit: a net margin of 6.4% against 5.8%.
| Latest fiscal year | NephrosNEPH, 2025 | Jin Medical InternationalZJYL, 2025 |
|---|---|---|
| Revenue | $18.8m | $20.7m |
| Revenue growth | 32.7% | -12.0% |
| Net income | $1.2m | $1.2m |
| Operating margin | 6.1% | — |
| Net margin | 6.4% | 5.8% |
| Return on equity | 12.7% | 4.1% |
| Free cash flow | $1.6m | −$3.7m |
| Cash | $5.4m | $7.5m |
| Total debt | $0 | $18.8m |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $35.1m | $412m |
| Price vs our value range | — | — |
| Moat score | 31 (Weak) | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |